Angiogenic Factors in Cord Blood of Preterm Infants Predicts Subsequently Developing Bronchopulmonary Dysplasia

Pediatrics and Neonatology

Volumn 56, Issue 6, 2015, Pages 382-385

  Yang, Wen Chien ^a   Chen, Chien Yi ^a   Chou, Hung Chieh ^a   Hsieh, Wu Shiun ^a   Tsao, Po Nien ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

bronchopulmonary dysplasia; placenta growth factor; soluble fms like tyrosine kinase 1; vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; BIOLOGICAL MARKER; OXYGEN; PLACENTAL GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; FLT1 PROTEIN, HUMAN; PGF PROTEIN, HUMAN; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; ARTIFICIAL VENTILATION; GESTATIONAL AGE; HUMAN; INCIDENCE; INFANT; LOW BIRTH WEIGHT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; PREMATURITY; RESPIRATORY DISTRESS SYNDROME; UMBILICAL CORD BLOOD; BIRTH WEIGHT; BLOOD; FEMALE; FETUS BLOOD; MALE; NEWBORN; PREGNANCY;

BIOMARKERS; BIRTH WEIGHT; BRONCHOPULMONARY DYSPLASIA; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PLACENTA GROWTH FACTOR; PREGNANCY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84952865147     PISSN: 18759572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pedneo.2015.02.001     Document Type: Article

References (27)

1. W.H. Northway Jr., R.C. Rosan, and D.Y. Porter Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia N Engl J Med 276 1967 357 368
2. L. Charafeddine, C.T. D'Angio, and D.L. Phelps Atypical chronic lung disease patterns in neonates Pediatrics 103 1999 759 765
3. A.N. Husain, N.H. Siddiqui, and J.T. Stocker Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia Hum Pathol 29 1998 710 717
4. A.J. Jobe The new BPD: an arrest of lung development Pediatr Res 46 1999 641 643
5. M. Jakkula, T.D. Le Cras, S. Gebb, K.P. Hirth, R.M. Tuder, N.F. Voelkel, and et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung Am J Physiol Lung Cell Mol Physiol 279 2000 L600 L607
6. Y. Kasahara, R.M. Tuder, L. Taraseviciene-Stewart, T.D. Le Cras, S. Abman, P.K. Hirth, and et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema J Clin Invest 106 2000 1311 1319
7. K.R. Stenmark, and S.H. Abman Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia Annu Rev Physiol 67 2005 623 661
8. S.H. Abman Bronchopulmonary dysplasia: "A vascular hypothesis" Am J Respir Crit Care Med 164 2001 1755 1756
9. J.R. Tang, S.A. Karumanchi, G. Seedorf, N. Markham, and S.H. Abman Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia Am J Physiol Lung Cell Mol Physiol 302 2012 L36 46
10. T.D. Le Cras, N.E. Markham, R.M. Tuder, N.F. Voelkel, and S.H. Abman Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure Am J Physiol Lung Cell Mol Physiol 283 2002 L555 L562
11. Y. Kasahara, R.M. Tuder, C.D. Cool, D.A. Lynch, S.C. Flores, and N.F. Voelkel Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema Am J Respir Crit Care Med 163 2001 737 744
12. P.N. Tsao, Y.N. Su, H. Li, P.H. Huang, C.T. Chien, Y.L. Lai, and et al. Overexpression of placenta growth factor contributes to the pathogenesis of pulmonary emphysema Am J Respir Crit Care Med 169 2004 505 511
13. P.N. Tsao, S.C. Wei, Y.N. Su, C.N. Lee, H.C. Chou, W.S. Hsieh, and et al. Placenta growth factor elevation in the cord blood of premature neonates predicts poor pulmonary outcome Pediatrics 113 2004 1348 1351
14. P.N. Tsao, S.C. Wei, H.C. Chou, Y.N. Su, C.Y. Chen, F.J. Hsieh, and et al. Vascular endothelial growth factor in preterm infants with respiratory distress syndrome Pediatr Pulmonol 39 2005 461 465
15. P.N. Tsao, S.C. Wei, Y.N. Su, H.C. Chou, C.Y. Chen, and W.S. Hsieh Excess soluble fms-like tyrosine kinase 1 and low platelet counts in premature neonates of preeclamptic mothers Pediatrics 116 2005 468 472
16. B. Thébaud Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity Neonatology 91 2007 291 297
17. C. Galambos, Y.S. Ng, A. Ali, A. Noguchi, S. Lovejoy, P.A. D'Amore, and et al. Defective pulmonary development in the absence of heparin-binding vascular endothelial growth factor isoforms Am J Respir Cell Mol Biol 27 2002 194 203
18. B. Thébaud, F. Ladha, E.D. Michelakis, M. Sawicka, G. Thurston, F. Eaton, and et al. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization Circulation 112 2005 2477 2486
19. A.M. Kunig, V. Balasubramaniam, N.E. Markham, D. Morgan, G. Montgomery, T.R. Grover, and et al. Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats Am J Physiol Lung Cell Mol Physiol 289 2005 L529 L535
20. A.M. Kunig, V. Balasubramaniam, N.E. Markham, G. Seedorf, J. Gien, and S.H. Abman Recombinant human VEGF treatment transiently increases lung edema but enhances lung structure after neonatal hyperoxia Am J Physiol Lung Cell Mol Physiol 291 2006 L1068 L1078
21. S.E. Maynard, J.Y. Min, J. Merchan, K.H. Lim, J. Li, S. Mondal, and et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649 658
22. S. Ahmad, and A. Ahmed Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia Circ Res 95 2004 884 891
23. R.J. Levine, S.E. Maynard, C. Qian, K.H. Lim, L.J. England, K.F. Yu, and et al. Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 2004 672 683
24. R. Thadhani, W.P. Mutter, M. Wolf, R.J. Levine, R.N. Taylor, V.P. Sukhatme, and et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia J Clin Endocrinol Metab 89 2004 770 775
25. M. Clauss, H. Weich, G. Breier, U. Knies, W. Röckl, J. Waltenberger, and et al. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis J Biol Chem 271 1996 17629 17634
26. S.K. Selvaraj, R.K. Giri, N. Perelman, C. Johnson, P. Malik, and V.K. Kalra Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor Blood 102 2003 1515 1524
27. S.L. Cheng, H.C. Wang, C.J. Yu, P.N. Tsao, P. Carmeliet, S.J. Cheng, and et al. Prevention of elastase-induced emphysema in placenta growth factor knock-out mice Respir Res 10 2009 115